Showing results (571-580 of 585) with videos related to
Sort By:
Pageof 59
Practical Radiation Oncology|January 18, 2026
Executive Summary of the American Radium Society™ (ARS) Appropriate Use Criteria (AUC) for Management of Locally Advanced Endometrial CancerMary McGunigal, Tracy Sherertz, Fernanda Musa, et al.JAMA Dermatology|February 9, 2022
Human Polyomavirus 9-An Emerging Cutaneous and Pulmonary Pathogen in Solid Organ Transplant RecipientsNischay Mishra, James Ng, Mark A Strom, et al.Clinical Therapeutics|December 8, 2000
Effects of losartan and candesartan monotherapy and losartan/hydrochlorothiazide combination therapy in patients with mild to moderate hypertension. Losartan Trial InvestigatorsA J Manolis, E Grossman, B Jelakovic, et al.Liver Cancer|May 14, 2026
A Phase 1b Study of Botensilimab and Balstilimab in Treatment-Refractory Hepatocellular CarcinomaAnthony B El-Khoueiry, Christopher H Lieu, Ghassan K Abou-Alfa, et al.Medrxiv : the Preprint Server for Health Sciences|March 30, 2023
A Large-Scale Proteomics Resource of Circulating Extracellular Vesicles for Biomarker Discovery in Pancreatic CancerBruno Bockorny, Lakshmi Muthuswamy, Ling Huang, et al.Elife|December 18, 2024
A large-scale proteomics resource of circulating extracellular vesicles for biomarker discovery in pancreatic cancerBruno Bockorny, Lakshmi Muthuswamy, Ling Huang, et al.Cancer Research Communications|March 27, 2023
A Preclinical and Phase Ib Study of Palbociclib plus Nab-Paclitaxel in Patients with Metastatic Adenocarcinoma of the PancreasManuel Hidalgo, Rocio Garcia-Carbonero, Kian-Huat Lim, et al.Journal for Immunotherapy of Cancer|December 23, 2025
Botensilimab (Fc-enhanced anti-CTLA-4 antibody) plus balstilimab (anti-PD-1 antibody) in patients with treatment-refractory ovarian cancerRebecca Porter, Bruno Bockorny, Bradley R Corr, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 27, 2025
Botensilimab (Fc-enhanced anti-cytotoxic lymphocyte-association protein-4 antibody) Plus Balstilimab (anti-PD-1 antibody) in Patients With Relapsed/Refractory Metastatic SarcomasBreelyn A Wilky, Gary K Schwartz, Michael S Gordon, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 18, 2021
Organoid Sensitivity Correlates with Therapeutic Response in Patients with Pancreatic CancerJoseph E Grossman, Lakshmi Muthuswamy, Ling Huang, et al.Pageof 59